NCT05602168View on ClinicalTrials.gov

Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance

NANot yet recruitingINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2030

Conditions

Hematologic Cancer

Interventions

OTHER

experimental:Acute leukemia/myelodysplastic or myeloproliferative disease

blood sampling, bone marrow aspirate and buccal swab

All Listed Sponsors

lead

Institut Paoli-Calmettes

OTHER

NCT05602168 - Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance | Biotech Hunter | Biotech Hunter